WallStreetZenWallStreetZen

NASDAQ: VRNA
Verona Pharma PLC Stock Ownership - Who owns Verona Pharma?

Insider buying vs selling

Have Verona Pharma PLC insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Kathleen A. RickardChief Medical Officer2024-02-0536,248$2.22
$80.51kSell
Mark W. HahnChief Financial Officer2024-02-01480,664$2.29
$1.10MSell
David ZaccardelliPresident and CEO2024-02-01480,200$2.29
$1.10MSell
Claire PollGeneral Counsel2024-02-01103,408$2.29
$237.22kSell
Kathleen A. RickardChief Medical Officer2024-02-0172,768$2.29
$166.93kSell
Martin EdwardsDirector2023-11-2033,736$1.84
$61.97kBuy
David R. EbsworthDirector2023-11-06160,000$1.98
$316.16kBuy
Kathleen A. RickardChief Medical Officer2023-11-0358,752$1.92
$112.80kSell
Claire PollGeneral Counsel2023-11-01173,904$1.74
$303.29kSell
David ZaccardelliPresident and CEO2023-11-01809,008$1.74
$1.41MSell

1 of 5

VRNA insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when VRNA insiders and whales buy or sell their stock.

VRNA Shareholders

What type of owners hold Verona Pharma PLC stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Access Industries Holdings LLC7.91%51,111,648$790.70MInsider
Forest Baskett6.32%40,868,505$632.24MInsider
Mohamad Makhzoumi6.32%40,868,505$632.24MInsider
Joshua Makower6.32%40,868,505$632.24MInsider
Scott D. Sandell6.32%40,868,505$632.24MInsider
Peter W. Sonsini6.32%40,868,505$632.24MInsider
Anthony A. Florence Jr.6.32%40,868,505$632.24MInsider
Andrew Sinclair3.04%19,660,001$304.14MInsider
David Zaccardelli2.47%15,942,592$246.63MInsider
Mark W. Hahn2.32%15,031,576$232.54MInsider

1 of 3

VRNA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
VRNA10.44%55.94%Net SellingNet Selling
LGND14.99%85.01%Net SellingNet Buying
KNSA48.25%9.83%Net SellingNet Selling
SLNO20.62%79.38%Net BuyingNet Selling
XNCR66.74%33.26%Net BuyingNet Selling

Verona Pharma Stock Ownership FAQ

Who owns Verona Pharma?

Verona Pharma (NASDAQ: VRNA) is owned by 10.44% institutional shareholders, 55.94% Verona Pharma insiders, and 33.63% retail investors. Access Industries Holdings LLC is the largest individual Verona Pharma shareholder, owning 51.11M shares representing 7.91% of the company. Access Industries Holdings LLC's Verona Pharma shares are currently valued at $790.70M.

If you're new to stock investing, here's how to buy Verona Pharma stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.